NURO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Neurometrix Inc (NURO).


$8.11M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

NURO Market Cap. (MRY)


NURO Shares Outstanding (MRY)


NURO Assets (MRY)


Total Assets

$15.32M

Total Liabilities

$1.01M

Total Investments

$11.67M

NURO Income (MRY)


Revenue

$3.03M

Net Income

-$7.81M

Operating Expense

$10.46M

NURO Cash Flow (MRY)


CF Operations

-$7.13M

CF Investing

$5.35M

CF Financing

$1.48M

NURO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

NURO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$15,324,127 (-28.47%)

$21,424,441 (-13.15%)

$24,669,615 (-0.88%)

$24,888,192 (211.31%)

Assets Current

$15,013,511 (-28.01%)

$20,854,442 (-13.49%)

$24,106,987 (-0.33%)

$24,187,859 (241.16%)

Assets Non-Current

$310,616 (-45.51%)

$569,999 (1.31%)

$562,628 (-19.66%)

$700,333 (-22.59%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$14,311,651 (-28.77%)

$20,091,317 (-13.98%)

$23,355,687 (0.60%)

$23,215,786 (342.39%)

Property Plant & Equipment Net

$310,616 (-42.86%)

$543,599 (1.37%)

$536,228 (-20.43%)

$673,933 (-23.08%)

Cash & Equivalents

$1,427,784 (-17.56%)

$1,731,946 (-60.05%)

$4,335,020 (-80.79%)

$22,572,104 (331.90%)

Accumulated Other Comprehensive Income

$60,949 (-74.62%)

$240,171 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$11,667,250 (-28.27%)

$16,265,205 (-3.55%)

$16,864,707 (0%)

$0 (0%)

Investments Current

$11,667,250 (-28.27%)

$16,265,205 (-3.55%)

$16,864,707 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$1,347,507 (-13.59%)

$1,559,428 (-3.44%)

$1,614,987 (128.57%)

$706,553 (-32.79%)

Trade & Non-Trade Receivables

$192,916 (-62.82%)

$518,824 (-19.78%)

$646,771 (108.09%)

$310,818 (-7.02%)

Trade & Non-Trade Payables

$363,304 (68.58%)

$215,509 (-41.45%)

$368,082 (29.59%)

$284,036 (99.58%)

Accumulated Retained Earnings (Deficit)

-$217,915,408 (-3.72%)

-$210,109,353 (-3.21%)

-$203,579,866 (-2.22%)

-$199,163,257 (-1.16%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$107,352 (-55.43%)

$240,876 (-32.32%)

$355,907 (-33.50%)

$535,215 (-49.56%)

Debt Current

$107,352 (-27.66%)

$148,391 (0.00%)

$148,391 (-35.06%)

$228,506 (-61.89%)

Debt Non-Current

$0 (0%)

$92,485 (-55.43%)

$207,516 (-32.34%)

$306,709 (-33.53%)

Total Liabilities

$1,012,476 (-24.05%)

$1,333,124 (1.46%)

$1,313,928 (-21.43%)

$1,672,406 (-39.11%)

Liabilities Current

$1,012,476 (-18.39%)

$1,240,639 (12.13%)

$1,106,412 (-18.99%)

$1,365,697 (-40.24%)

Liabilities Non-Current

$0 (0%)

$92,485 (-55.43%)

$207,516 (-32.34%)

$306,709 (-33.53%)

NURO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$3,032,837 (-48.61%)

$5,901,425 (-28.52%)

$8,256,073 (0.03%)

$8,253,493 (11.87%)

Cost of Revenue

$1,353,170 (-30.75%)

$1,954,012 (-22.02%)

$2,505,833 (7.46%)

$2,331,833 (9.56%)

Selling General & Administrative Expense

$8,669,094 (4.18%)

$8,320,974 (14.74%)

$7,252,281 (29.28%)

$5,609,852 (13.26%)

Research & Development Expense

$1,792,610 (-35.47%)

$2,777,960 (-14.25%)

$3,239,725 (24.78%)

$2,596,415 (8.58%)

Operating Expenses

$10,461,704 (-5.74%)

$11,098,934 (5.78%)

$10,492,006 (27.85%)

$8,206,267 (11.73%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$7,806,055 (-19.55%)

-$6,529,487 (-47.84%)

-$4,416,609 (-93.59%)

-$2,281,457 (-9.05%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$7,806,055 (-19.55%)

-$6,529,487 (-47.84%)

-$4,416,609 (-93.59%)

-$2,281,457 (-9.05%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$7,806,055 (-19.55%)

-$6,529,487 (-47.84%)

-$4,416,609 (-93.59%)

-$2,281,457 (-9.05%)

Weighted Average Shares

$1,969,858 (83.43%)

$1,073,922 (10.75%)

$969,653 (-85.41%)

$6,645,397 (75.59%)

Weighted Average Shares Diluted

$1,969,858

-

-

-

Earning Before Interest & Taxes (EBIT)

-$7,806,055 (-19.55%)

-$6,529,487 (-47.84%)

-$4,416,609 (-93.59%)

-$2,281,457 (-9.05%)

Gross Profit

$1,679,667 (-57.45%)

$3,947,413 (-31.35%)

$5,750,240 (-2.89%)

$5,921,660 (12.80%)

Operating Income

-$8,782,037 (-22.80%)

-$7,151,521 (-50.82%)

-$4,741,766 (-107.55%)

-$2,284,607 (-9.06%)

NURO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$5,347,890 (362.48%)

$1,156,353 (106.84%)

-$16,893,451 (-12726.25%)

-$131,710 (0%)

Net Cash Flow from Financing

$1,476,301 (-36.52%)

$2,325,441 (-39.82%)

$3,864,031 (-80.24%)

$19,551,295 (369.21%)

Net Cash Flow from Operations

-$7,128,353 (-17.15%)

-$6,084,868 (-15.04%)

-$5,289,416 (-155.07%)

-$2,073,694 (-0.33%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$304,162 (88.32%)

-$2,603,074 (85.79%)

-$18,318,836 (-205.61%)

$17,345,891 (725.99%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$5,347,890 (299.13%)

$1,339,895 (107.94%)

-$16,870,269 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$183,542 (-691.74%)

-$23,182 (82.40%)

-$131,710 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$1,476,301 (-36.52%)

$2,325,441 (-39.82%)

$3,864,031 (-80.24%)

$19,551,295 (369.21%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$729,310 (4.26%)

$699,505 (46.63%)

$477,062 (-31.67%)

$698,173 (16.53%)

Depreciation Amortization & Accretion

$232,983 (318.19%)

$55,712 (12.80%)

$49,391 (-35.33%)

$76,378 (-15.09%)

NURO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

55.40% (-17.19%)

66.90% (-3.88%)

69.60% (-2.93%)

71.70% (0.70%)

Profit Margin

-257.40% (-132.73%)

-110.60% (-106.73%)

-53.50% (-93.84%)

-27.60% (2.82%)

EBITDA Margin

-249.70% (-127.62%)

-109.70% (-107.37%)

-52.90% (-98.13%)

-26.70% (1.48%)

Return on Average Equity (ROAE)

-47.10% (-50.48%)

-31.30% (-64.74%)

-19.00% (-28.38%)

-14.80% (67.04%)

Return on Average Assets (ROAA)

-43.30% (-47.78%)

-29.30% (-66.48%)

-17.60% (-34.35%)

-13.10% (51.30%)

Return on Sales (ROS)

-257.40% (-132.73%)

-110.60% (-106.73%)

-53.50% (-93.84%)

-27.60% (2.82%)

Return on Invested Capital (ROIC)

-50.50% (-50.30%)

-33.60% (-13.51%)

-29.60% (78.72%)

-139.10% (-27.97%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1 (-74.74%)

-0.57 (76.11%)

-2.4 (78.46%)

-11.16 (-143.58%)

Price to Sales Ratio (P/S)

2.58 (293.74%)

0.66 (-53.21%)

1.4 (-65.36%)

4.04 (149.35%)

Price to Book Ratio (P/B)

0.57 (195.31%)

0.19 (-61.21%)

0.49 (-65.55%)

1.44 (-36.95%)

Debt to Equity Ratio (D/E)

0.07 (7.58%)

0.07 (17.86%)

0.06 (-22.22%)

0.07 (-86.23%)

Earnings Per Share (EPS)

-3.96 (36.84%)

-6.27 (-26.41%)

-4.96 (-1002.22%)

-0.45 (34.78%)

Sales Per Share (SPS)

1.54 (-71.97%)

5.5 (-35.46%)

8.51 (585.51%)

1.24 (-36.28%)

Free Cash Flow Per Share (FCFPS)

-3.62 (38.00%)

-5.84 (-6.53%)

-5.48 (-1550.30%)

-0.33 (39.19%)

Book Value Per Share (BVPS)

7.26 (-61.17%)

18.71 (-22.33%)

24.09 (589.38%)

3.49 (151.91%)

Tangible Assets Book Value Per Share (TABVPS)

7.78 (-61.01%)

19.95 (-21.59%)

25.44 (579.36%)

3.75 (77.32%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

-2 (60.00%)

-5 (-25.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.97 (-134.38%)

-0.41 (82.26%)

-2.33 (52.56%)

-4.91 (-19.68%)

Asset Turnover

0.17 (-36.60%)

0.27 (-19.70%)

0.33 (-30.38%)

0.47 (-50.00%)

Current Ratio

14.83 (-11.78%)

16.81 (-22.85%)

21.79 (23.02%)

17.71 (470.95%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$7,128,353 (-13.72%)

-$6,268,410 (-17.99%)

-$5,312,598 (-140.89%)

-$2,205,404 (-6.70%)

Enterprise Value (EV)

$7,330,576 (173.85%)

$2,676,826 (-73.67%)

$10,168,346 (-6.03%)

$10,820,672 (31.81%)

Earnings Before Tax (EBT)

-$7,806,055 (-19.55%)

-$6,529,487 (-47.84%)

-$4,416,609 (-93.59%)

-$2,281,457 (-9.05%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$7,573,072 (-16.98%)

-$6,473,775 (-48.24%)

-$4,367,218 (-98.05%)

-$2,205,079 (-10.13%)

Invested Capital

$12,991,219 (-30.50%)

$18,692,732 (-4.55%)

$19,584,090 (1218.26%)

$1,485,606 (-3.78%)

Working Capital

$14,001,035 (-28.62%)

$19,613,803 (-14.72%)

$23,000,575 (0.78%)

$22,822,162 (375.02%)

Tangible Asset Value

$15,324,127 (-28.47%)

$21,424,441 (-13.15%)

$24,669,615 (-0.88%)

$24,888,192 (211.31%)

Market Capitalization

$8,109,475 (109.76%)

$3,866,118 (-66.55%)

$11,558,267 (-65.35%)

$33,359,893 (178.94%)

Average Equity

$16,589,659 (-20.45%)

$20,854,758 (-10.27%)

$23,242,608 (51.07%)

$15,384,994 (230.46%)

Average Assets

$18,026,764 (-19.07%)

$22,273,691 (-11.09%)

$25,051,857 (43.83%)

$17,417,906 (123.69%)

Invested Capital Average

$15,466,874 (-20.35%)

$19,419,054 (30.22%)

$14,912,981 (809.36%)

$1,639,941 (-14.81%)

Shares

2,042,689 (90.21%)

1,073,922 (10.75%)

969,653 (-85.41%)

6,645,397 (75.59%)